The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 30, 2006
Filed:
Nov. 20, 2001
Hideki Fujikura, Nagano, JP;
Toshihiro Nishimura, Nagano, JP;
Nobuhiko Fushimi, Nagano, JP;
Kazuya Tatani, Nagano, JP;
Norihiko Kikuchi, Nagano, JP;
Kenji Katsuno, Nagano, JP;
Masayuki Isaji, Nagano, JP;
Hideki Fujikura, Nagano, JP;
Toshihiro Nishimura, Nagano, JP;
Nobuhiko Fushimi, Nagano, JP;
Kazuya Tatani, Nagano, JP;
Norihiko Kikuchi, Nagano, JP;
Kenji Katsuno, Nagano, JP;
Masayuki Isaji, Nagano, JP;
Kissei Pharmaceutical Co., Ltd., Nagano, JP;
Abstract
The present invention relates to glucopyranosyloxybenzylbenzene derivatives represented by the general formula: wherein Rrepresents a hydrogen atom, a hydroxy group, a substituted or unsubstituted amino group, a carbamoyl group, a substituted or unsubstituted (lower alkyl) group, a substituted or unsubstituted (lower alkoxy) group etc.; Rrepresents a hydrogen atom or a lower alkyl group; and Rrepresents a substituted or unsubstituted (lower alkyl) group, a substituted or unsubstituted (lower alkoxy) group, a substituted or unsubstituted (lower alkylthio) group etc., or pharmaceutically acceptable salts thereof, which have an inhibitory activity in human SGLT2 and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, diabetic complication or obesity, pharmaceutical compositions comprising the same and intermediates thereof.